Medicine Was Built for a 70-Kilogram Man — And Women Are Paying the Price

There's a reference human being baked into the foundation of modern medicine. He's about 5'7", weighs roughly 154 pounds, and his hormones don't fluctuate much from week to week. He was the default subject in most clinical trials for the better part of the 20th century.

He is, obviously, a man.

And if you're a woman living in the United States right now, trying to navigate a healthcare system that was largely designed around that fictional guy — you've probably felt the friction. Maybe your symptoms got brushed off. Maybe a medication made you feel terrible in ways your doctor didn't expect. Maybe you were told your lab results were "normal" while you felt anything but.

This isn't paranoia. It's documented history.

The Research Gap Nobody Talks About

In 1977, the FDA formally recommended that women of childbearing age be excluded from early-phase clinical trials. The stated concern was protecting potential fetuses from experimental compounds. The unintended consequence? A generation of drugs, dosages, and diagnostic benchmarks built almost entirely on male biology.

That policy wasn't fully reversed until 1993, when the NIH Revitalization Act required that women and minorities be included in federally funded research. But here's the thing — changing a policy doesn't instantly rewrite decades of accumulated medical knowledge. The textbooks, the treatment algorithms, the "normal" reference ranges on your lab work? A lot of that still traces back to studies that never had a female subject in the room.

And even after 1993, including women in trials didn't automatically mean accounting for where they were in their menstrual cycle, whether they were on hormonal contraceptives, or how their physiology might shift across the lifespan. Checking the box isn't the same as doing the science.

Your Heart Attack Doesn't Look Like His

Let's talk about heart disease, because this is where the stakes get genuinely life-or-death.

Heart disease is the number one killer of American women — responsible for about one in five female deaths each year, according to the CDC. And yet women are still significantly more likely than men to be misdiagnosed when they're having a cardiac event.

Why? Because the "classic" heart attack presentation — crushing chest pain radiating down the left arm — was largely derived from studying men. Women more often experience what clinicians call atypical symptoms: jaw pain, nausea, extreme fatigue, shortness of breath, back pain. These get attributed to anxiety, acid reflux, or stress. Women get sent home. And sometimes, they don't come back.

A 2018 study published in the European Heart Journal found that women were significantly more likely to die within 28 days of a heart attack than men — partly because of delayed diagnosis and treatment. The researchers pointed to the mismatch between how women present and what emergency medicine was trained to look for.

That's not a gap in female biology. That's a gap in how medicine was taught.

Hormones as Variables, Not Noise

Here's something that tends to get overlooked in conventional clinical practice: women's physiology isn't static. Hormone levels — estrogen, progesterone, testosterone — shift dramatically across the menstrual cycle, across pregnancy, across perimenopause and beyond. Those shifts affect everything from immune function and pain perception to how drugs are metabolized in the liver.

Most drug dosing guidelines don't account for any of that.

Take sleep medications as one example. A 2013 FDA safety announcement found that women metabolize zolpidem (the active ingredient in Ambien) significantly more slowly than men — meaning they were waking up with dangerous levels of the drug still active in their system. The FDA responded by cutting the recommended dose for women in half. This was decades after the drug had been on the market.

How many other drugs have the same problem and we just haven't caught it yet? That's not a rhetorical question. Researchers are genuinely still working through it.

The Autoimmune Blind Spot

About 80% of autoimmune disease diagnoses in the US occur in women. Conditions like lupus, Hashimoto's thyroiditis, rheumatoid arthritis, and multiple sclerosis disproportionately affect female patients — and they're also among the most likely to be dismissed or delayed in diagnosis.

The average time from first symptom to diagnosis for lupus is nearly six years. For endometriosis, it's closer to seven to ten years. During that window, women are often told their symptoms are psychosomatic, stress-related, or simply not serious enough to investigate further.

Forward-thinking practitioners — functional medicine doctors, integrative gynecologists, some progressive rheumatologists — are pushing back on this. They're looking at hormonal fluctuations as meaningful clinical data rather than inconvenient variables. They're tracking symptoms across the menstrual cycle. They're running expanded lab panels instead of relying on a single TSH or a basic metabolic panel to declare someone "fine."

It's not radical. It's just actually paying attention to the patient in front of you.

What Doing It Differently Looks Like

Some practitioners are now practicing what's being called cycle-informed care — adjusting treatment approaches based on where a patient is in their hormonal cycle. This might mean timing certain interventions, adjusting supplement protocols, or simply documenting symptom patterns over time to identify what's actually driving a problem.

Others are leaning into precision medicine tools — genetic testing, continuous glucose monitoring, detailed hormone panels that go beyond the basics — to build a clearer picture of how an individual woman's body actually functions, rather than comparing her to a reference range derived from a population that didn't include her.

This is the direction medicine needs to go. Not because women deserve special treatment — but because they deserve accurate treatment.

The Renegade Takeaway

If you're a woman who's been told your bloodwork is normal while you feel exhausted, in pain, or just fundamentally off — you're not imagining it. The system has a structural blind spot that's been built up over decades, and it doesn't fix itself overnight.

Ask questions. Push for expanded testing. Seek out practitioners who treat your hormonal cycle as relevant information, not background noise. And if a doctor dismisses your symptoms without investigation, that's data too — data that it might be time to find someone else.

Your body isn't the problem. The reference model is.